Eldico secures new funding to drive global expansion and enhance commercial operations
08.10.2024
Eldico Scientific has completed a funding round, attracting investments from both institutional and private sources, aimed at accelerating its global expansion and strengthening its commercial capabilities. With over 100 customers worldwide, Eldico continues to establish itself as a leader in electron diffraction technology for crystallography, setting the stage for further growth in international markets.
 Eldico
|
 |
Venture Kick alumnus Eldico, founded in 2019 at Switzerland Innovation Park Innovaare, has become a leader in electron diffraction with its ELDICO ED-1 electron diffractometer. This technology accelerates nano-crystalline material analysis, providing results in hours instead of days. Clients can either buy the ED-1 or use ELDICO’s Measurements-as-a-Service (MaaS) model.
The ED-1 is particularly valuable to industries like pharmaceuticals and advanced materials, and Eldico’s clients include Boehringer Ingelheim and Roche. A key partnership with US-based Triclinic Labs marks its expansion into North America, with further growth planned in India and China.
Eldico’s recent funding supports global expansion, and the company now employs 12 specialists, including five PhDs. Leadership includes new CEO James Berwick and CTO Rolf Burgmer.
Eldico's scientific team
The ED-1 is particularly valuable to industries like pharmaceuticals and advanced materials, and Eldico’s clients include Boehringer Ingelheim and Roche. A key partnership with US-based Triclinic Labs marks its expansion into North America, with further growth planned in India and China.
Eldico’s recent funding supports global expansion, and the company now employs 12 specialists, including five PhDs. Leadership includes new CEO James Berwick and CTO Rolf Burgmer.
Eldico's scientific team